Pertuzumab is manufactured by Roche and is used to treat cancer. ## Compulsory licenses A compulsory licence application is currently pending for Pertuzumab in Switzerland. The application was submitted by Public Eye. ## Other products issued by the same manufacturer [[Erlotinib]] [[Oseltamivir]] [[NFV]] [[T-20]] [[Trastuzumab-Emtansine]] [[Pertuzumab]] ## Other products for the same disease [[Erlotinib]] [[Imatinib]] [[Letrozole]] [[Sunitinib, erlotinib]] [[Gemcitabine]] [[Trastuzumab-Emtansine]] [[Dasatinib]] [[Docetaxel]] [[Sorafenib Tosylate]] [[Sunitinib]]